Adriana Becerra, a patient diagnosed with breast cancer, is currently highlighting the urgent challenges associated with obtaining timely, uninterrupted medical care within the Colombian healthcare system, specifically involving her provider, Coosalud. For patients facing oncological diagnoses, administrative delays in the authorization of chemotherapy, radiotherapy, or surgical procedures can significantly impact prognosis, as clinical guidelines emphasize that treatment continuity is essential for managing disease progression.
According to the World Health Organization (WHO), breast cancer is the most common cancer globally, and the effectiveness of treatment is highly dependent on early detection and the absence of delays in the clinical pathway. In Colombia, the “Ley Estatutaria de Salud” (Law 1751 of 2015) establishes that the right to health is fundamental and autonomous, meaning that health entities are legally obligated to provide timely and comprehensive services without administrative barriers. Patients experiencing interruptions in their care, such as those reported by individuals navigating authorization processes with Health Promoting Entities (EPS), have recourse through legal mechanisms like the “acción de tutela” to protect their constitutional rights to life and health.
Understanding Patient Rights and Administrative Barriers
The experience of patients like Adriana Becerra underscores a recurring issue within the Colombian EPS system: the friction between administrative authorization processes and the clinical urgency of cancer treatment. When a patient faces a delay, the first step recommended by the Superintendencia de Salud—the government body responsible for overseeing health entities—is to file a formal complaint through the patient advocacy office of the specific EPS. If the delay persists, the Ministry of Health and Social Protection provides guidance on filing a “derecho de petición,” which mandates a formal response from the institution within a set timeframe.
In cases where administrative hurdles persist despite these measures, the Colombian judiciary remains the primary avenue for relief. The “acción de tutela” is a summary legal proceeding designed to provide immediate protection of fundamental rights. According to rulings by the Constitutional Court of Colombia, the right to health includes the principle of “integralidad,” which dictates that patients must receive all necessary services—including medication, procedures, and follow-up care—without being forced to repeatedly request authorizations for every individual step of their treatment plan.
The Clinical Importance of Treatment Continuity
Oncologists emphasize that cancer treatment protocols are meticulously scheduled to maximize therapeutic efficacy. Interruptions, whether due to bureaucratic delays or supply chain issues, can lead to the development of treatment resistance or the further spread of malignant cells. For a patient, the stress of navigating these administrative systems can exacerbate the physical toll of the disease. Health advocacy groups often advise patients to maintain a detailed “bitácora” or log of all medical appointments, authorization numbers, and communications with their provider to facilitate legal or administrative interventions if care is disrupted.
For those currently facing obstacles in their cancer treatment, the Superintendencia de Salud maintains a digital portal for reporting service denials. Additionally, the Defensoría del Pueblo offers legal support for patients who require assistance in enforcing their right to timely healthcare. These resources are intended to bridge the gap between policy mandates and the reality experienced by patients in the field.
Next Steps for Patients and Advocacy
Patients seeking to resolve care interruptions should verify that their medical records are complete and that their treating physician has submitted all necessary “MIPRES” (a technological tool for the prescription of health technologies) orders. The Superintendencia de Salud provides regular updates on the performance of health entities, which can be reviewed by the public to understand the status of their provider. As systemic challenges in the healthcare sector continue to be a subject of national policy debate, the focus remains on ensuring that administrative processes do not override the clinical necessity of rapid, consistent oncology care.
Readers who have experienced similar challenges or who wish to share their perspectives on the healthcare system are encouraged to participate in the conversation below. Ensuring that patient experiences are documented is a vital step in advocating for systemic improvements in the delivery of cancer care.